1. A Liouville theorem for the semilinear fractional CR covariant equation on the heisenberg group. Issue 8 (3rd August 2019) Authors: Wang, Xinjing; Cui, Xuewei; Niu, Pengcheng Journal: Complex variables and elliptic equations Issue: Volume 64:Issue 8(2019) Page Start: 1325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clostridium difficile toxin A and toxin B inhibit YAP in the colonic epithelial cells. Issue 2 (30th November 2020) Authors: Song, Jinglue; Shen, Xia; Huang, Zhenyu; Liu, Yun; Cui, Long; Cui, Xuewei; Liu, Chen‐Ying Journal: Journal of biochemical and molecular toxicology Issue: Volume 35:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Early prediction of bronchopulmonary dysplasia: can noninvasive monitoring methods be essential?. Issue 2 (3rd April 2023) Authors: Cui, Xuewei; Fu, Jianhua Journal: ERJ open research Issue: Volume 9:Issue 2(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Issue 10295 (10th July 2021) Authors: Rosenstock, Julio; Wysham, Carol; Frías, Juan P; Kaneko, Shizuka; Lee, Clare J; Fernández Landó, Laura; Mao, Huzhang; Cui, Xuewei; Karanikas, Chrisanthi A; Thieu, Vivian T Journal: Lancet Issue: Volume 398:Issue 10295(2021) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Issue 10160 (17th November 2018) Authors: Frias, Juan Pablo; Nauck, Michael A; Van, Joanna; Kutner, Mark E; Cui, Xuewei; Benson, Charles; Urva, Shweta; Gimeno, Ruth E; Milicevic, Zvonko; Robins, Deborah; Haupt, Axel Journal: Lancet Issue: Volume 392:Issue 10160(2018) Page Start: 2180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week, randomized, double‐blind, placebo‐controlled study to evaluate different dose‐escalation regimens. Issue 6 (11th February 2020) Authors: Frias, Juan Pablo; Nauck, Michael A.; Van, Joanna; Benson, Charles; Bray, Ross; Cui, Xuewei; Milicevic, Zvonko; Urva, Shweta; Haupt, Axel; Robins, Deborah A. Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 6(2020) Page Start: 938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficient Estimation of the Efficacy and Safety Endpoints for Clinical Trials with Preplanned Dose Titrations. (2nd January 2023) Authors: Qu, Yongming; Cui, Xuewei; Bray, Ross; Sun, Nicholas Journal: Statistics in biopharmaceutical research Issue: Volume 15:Number 1(2023) Page Start: 214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Intestinal vitamin D receptor signaling ameliorates dextran sulfate sodium‐induced colitis by suppressing necroptosis of intestinal epithelial cells. Issue 10 (11th August 2020) Authors: Shi, Yongyan; Cui, Xuewei; Sun, Yanli; Zhao, Qun; Liu, Tianjing Journal: FASEB journal Issue: Volume 34:Issue 10(2020) Page Start: 13494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Once‐weekly dulaglutide 1.5 mg restores insulin secretion in response to intravenous glucose infusion. Issue 4 (17th February 2017) Authors: de la Peña, Amparo; Loghin, Corina; Cui, Xuewei; Zhang, Xin; Kapitza, Christoph; Kelly, Ronan P. Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 4(2017) Page Start: 517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies (SURPASS programme). Issue 4 (20th January 2023) Authors: Kiyosue, Arihiro; Dunn, Julia P.; Cui, Xuewei; Hickey, Ana; Hirase, Tetsuaki; Imaoka, Takeshi; Heine, Robert J. Journal: Diabetes, obesity & metabolism Issue: Volume 25:Issue 4(2023) Page Start: 1056 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗